查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032478

血管閉合器械市場報告：按產品、入路方式、手術、最終用戶和地區分類（2026-2034 年）

Vascular Closure Devices Market Report by Product, Access, Procedure, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球血管閉合器械市場規模達16億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以4.71%的複合年成長率成長，到2034年達到25億美元。北美目前是領先的市場區域，這得益於其完善的醫療基礎設施、快速成長的醫療支出以及心血管疾病發病率的上升。此外，心血管疾病（CVD）盛行率的上升、對血管治療需求的成長、閉合器械技術的進步、人口老化推動微創（MI）治療的發展、新興市場醫療支出的增加以及對持續創新的不懈追求，都是推動市場成長的因素。

血管閉合器械市場趨勢：

心血管疾病發生率增加

由於全球心血管疾病發生率持續上升，血管閉合器械市場正經歷前所未有的成長。冠狀動脈疾病、心肌梗塞和周邊血管疾病患者數量的不斷增加，導致介入治療的需求也隨之成長。開發中國家和已開發國家人口老化加劇，接受導管介入診斷和治療的患者數量不斷增加，從而對有效的血管閉合解決方案提出了更高的要求。世界衛生組織（WHO）預測，60歲以上人口數量將從2023年的11億增加到2030年的14億。此外，診所和醫院正在使用血管閉合器械來最大限度地減少手動壓迫引起的併發症，尤其是在高風險心血管疾病患者中。肥胖、糖尿病、高血壓和久坐不動的生活方式等與文明病也加劇了這一趨勢，這些疾病共同增加了心血管事件的發生率。隨著心臟病負擔的加重，醫療專業人員越來越依賴血管閉合器械來確保患者術後安全可靠地康復。

擴大微創手術的使用範圍

由於微創心血管治療日益普及，血管閉合裝置的需求正在迅速成長。醫療專業人員和患者擴大選擇基於導管的手術，例如支架置入術和血管成形術，而非開胸手術，原因包括住院時間更短、恢復時間更短以及併發症風險更低。這一趨勢推動了對高效能血管閉合裝置需求的持續成長，這些裝置在導管插入術後閉合動脈穿刺點方面發揮著至關重要的作用。醫院正在採用這些裝置，以取代繁瑣耗時的手動壓迫方法，從而提高手術效率和病患舒適度。這得益於介入性心臟病學（心臟導管插入術）領域的不斷進步，該領域正在開發需要高效血管通路管理的新手術。隨著微創介入治療在已開發國家和開發中國家的醫療市場中日益普及，對先進閉合裝置的需求也不斷成長。根據IMARC Group預測，到2033年，全球微創手術市場預計將達到949億美元。

新興的血管閉合技術

血管閉塞器械市場的發展動力源於器械技術的持續創新，這些創新使器械更加安全、有效且易於使用。各公司紛紛推出採用更優質生物可吸收材料、微創穿刺和卓越密封機制的新一代產品。這些進步最大限度地降低了出血、感染和血管損傷等併發症的風險，從而最大限度地改善患者的治療效果和復原。研發工作致力於開發能夠適應更廣泛患者解剖結構和介入手術的器械，以拓展其在臨床實踐中的應用範圍。醫院和醫生擴大採用這些先進的解決方案，因為它們能夠簡化手術流程並降低整體治療成本。隨著技術的不斷進步，血管閉塞器材領域的競爭日益激烈，迫使各公司不斷創新。 2024年，專注於提供尖端解決方案以改善患者預後的全球醫療技術公司Hemonetics Corporation宣布其VASCADE MVP® XL中徑靜脈閉塞系統正式上市。 VASCADE MVP XL 系統現已在美國上市，是 Hemonetics 公司 VASCADE® 血管阻塞系統的最新改良版本。該系統採用先進的折疊式止血盤技術和獨特的可吸收膠原蛋白貼片，旨在促進快速止血。

血管閉塞裝置市場成長要素：

越來越重視患者的舒適度和術後復原。

血管閉塞裝置的市場成長主要得益於人們日益重視提高病患舒適度和加速術後復原。過去用於閉合股動脈穿刺的標準方法－手動壓迫，如今卻會帶來不適、延長休息時間，並導致病患滿意度下降。而血管閉塞裝置則能更快止血，使患者能夠更早下地行走並出院。這一趨勢與醫療保健領域以患者為中心的護理和改善復健流程的根本性轉變相契合。醫院擴大採用血管閉塞裝置來縮短病患住院時間，並最大限度地提高整體醫療效率。患者對能夠減輕疼痛和不適的微創技術的需求也進一步推動了市場需求。由於患者滿意度仍然是衡量醫療品質的關鍵指標，血管閉塞裝置在全球臨床實踐中日益受到重視。

新興市場醫療保健基礎設施的成長

新興經濟體醫療基礎設施的廣泛擴張推動了血管閉合器械市場的發展。亞太、拉丁美洲和中東國家正大力投資醫院現代化建設，並擴大先進心臟導管介入治療的覆蓋範圍。隨著醫療成本的上升和醫療基礎設施的改善，這些國家尋求血管成形術和導管介入治療的患者數量不斷增加，因此對高效的血管閉合解決方案的需求也日益迫切。各國政府和私人醫療機構越來越重視採用先進的醫療技術，以滿足不斷成長的心血管護理需求。這種成長為血管閉合器械製造商提供了進入新市場和建立穩固分銷管道的機會。隨著心血管健康意識宣傳活動的加強和早期診斷的推廣，這些市場對血管閉合器材的使用量進一步成長。這凸顯了成熟醫療體系和新興醫療體係對該市場日益成長的支持。

越來越多的臨床證據證實了其安全性和有效性

血管閉塞裝置的市場成長主要得益於越來越多的臨床證據，這些證據表明，與傳統的手動壓迫止血方法相比，血管閉塞裝置具有更高的安全性、可靠性和有效性。大量研究和臨床試驗表明，血管閉塞裝置能夠縮短止血時間、降低併發症率，並使患者能夠更早轉運。這些數據促使醫生和醫院將血管閉塞裝置作為介入性心臟病學手術的標準治療方法。基於這些可靠的數據，監管機構的核准不斷增加，使製造商能夠擴大產品供應範圍，並涵蓋多個地區。此外，同儕審查的研究也增強了醫學界的信心，醫師們優先選擇那些療效已被證實的裝置用於病患治療。不斷累積的科學證據確保了人們對這些技術的長期信心，並促進了它們在各種醫療機構中的應用。隨著臨床證據的不斷積累，血管閉塞裝置正成為現代心血管護理的重要組成部分。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球血管閉合裝置市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 被動式加速度計
    • 主要部分
      • 膠原蛋白塞
      • 密封劑或凝膠類裝置
      • 壓縮輔助裝置
  • 主動軸測儀
    • 主要部分
      • 使用縫線的裝置
      • 夾式裝置
  • 體外止血裝置

第7章 市場區隔：依通路分類

  • 大腿入口
  • 徑向通道

第8章 市場區隔：依治療方式分類

  • 介入性心臟病學
  • 介入性放射學/血管外科

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章：促進、抑制與機遇

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Cardiva Medical Inc.（Haemonetics Corporation）
    • Cordis Corporation（Cardinal Health Inc.）
    • ENDOCOR GmbH & Co. KG
    • Merit Medical Systems Inc.
    • Morris Innovative Inc.
    • Teleflex Incorporated
    • Terumo Medical Corporation（Terumo Corporation）
    • Transluminal Technologies LLC
    • Vasorum Ltd.
Product Code: SR112026A6791

The global vascular closure devices market size reached USD 1.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.71% during 2026-2034. North America currently is the leading region due to the well-developed healthcare infrastructure, burgeoning healthcare expenditure, and increased incidence of cardiovascular disorders. Moreover, the increasing prevalence of cardiovascular disease (CVDs), rising vascular procedures, technological advancements in closure devices, aging population demographics favoring minimally invasive (MI) treatments, expanding healthcare expenditure in emerging markets, and ongoing innovation efforts are some of the factors stimulating the market expansion.

VASCULAR CLOSURE DEVICES MARKET ANALYSIS:

  • Major Market Drivers: The growing adoption of catheterization procedures for the treatment of coronary artery disease and the increasing prevalence of cardiovascular diseases (CVDs) are the major factors driving the growth of the vascular closure devices market growth. The innovation in minimally invasive (MI) surgeries increases the adoption of such devices due to shorter recovery time and complications, which is boosting the market growth. Additionally, growing geriatric population prone to vascular diseases and the surging number of obese patients around the world have led to a higher incidence of CVDs, which, in turn, is accelerating the market growth. Additionally, the availability of advanced health care infrastructure, particularly in the developing countries, for non-surgical but advanced procedures like using vascular closure devices, is another growth-inducing factor. Moreover, the vascular closure devices market share is propelled by the increasing demand for diagnostic and therapeutic procedures, which are non-invasive and allow patient comfort and eliminate the likelihood of fast ambulation post-surgery.
  • Key Market Trends: Rapid innovation is one of the prominent drivers in the vascular closure devices market which has led to the growth of user-friendly devices. Moreover, the shifting preference towards bioresorbable or absorbable devices that aid to reduce risk of long-term complications and negate the need for device removal. Furthermore, active closure devices are increasingly being adopted in the market as they offer immediate hemostasis. Apart from this, personalized medicine is also gaining popularity as they are customizable to the patient's individual condition and anatomy. Apart from this, technology advancements have paved way to the development of telemedicine and remote monitoring, which are incorporating with post-procedural care leading to improved patient management after vascular closures, which is another key vascular closure devices market trends.
  • Geographical Trends: Regionally, North America is the most lucrative marketplace for the global vascular closure devices market on account of a well-developed healthcare infrastructure, burgeoning healthcare expenditure, and increased incidence of cardiovascular disorders. The market is competitive with strong regulatory support for medical devices by governments & research and development (R&D) Investments in the region. Europe is right behind with their steady progression towards advanced technologies and supportive healthcare policies. However, Asia-Pacific is expected to experience the highest rate of growth because of improved healthcare infrastructure, a growing number of medical tourism facilities in developing economies, and increased awareness of MI techniques.
  • Competitive Landscape: The competitive landscape of the market is characterized by the presence of companies, such as Abbott Laboratories, Cardiva Medical Inc. (Haemonetics Corporation), Cordis Corporation (Cardinal Health Inc.), ENDOCOR GmbH & Co. KG, Merit Medical Systems Inc., Morris Innovative Inc., Teleflex Incorporated, Terumo Medical Corporation (Terumo Corporation), Transluminal Technologies LLC, Vasorum Ltd., etc.
  • Challenges and Opportunities: The vascular closure devices market faces challenges such as stringent regulatory policies, which can delay product approvals and market entry. There is also a high cost associated with advanced technologies, limiting adoption in cost-sensitive markets. Moreover, the risk of complications such as infections and blood vessel damage pose a challenge to the market growth. However, these challenges present opportunities for innovation in developing safer and more effective closure devices. There is also a significant opportunity in emerging markets, where healthcare infrastructure improvements and increasing healthcare expenditure create a growing demand for advanced medical devices, which is driving the vascular closure devices market outlook.

VASCULAR CLOSURE DEVICES MARKET TRENDS:

Increasing Incidence of Cardiovascular Diseases

The vascular closure devices market is witnessing unprecedented growth as the incidence of cardiovascular diseases is steadily increasing globally. More patients are being diagnosed with coronary artery disease, heart attacks, and peripheral vascular disorders, which are triggering interventional procedures. With aging populations in developing and developed countries, more patients are receiving diagnostic and therapeutic catheterization procedures, thus generating high demand for effective closure solutions. As per the predictions of the World Health Organization (WHO), the number of individuals aged 60 and above will increase from 1.1 in 2023 to 1.4 billion by 2030. Moreover, clinics and hospitals are using vascular closure devices to minimize complications related to manual compression methods, particularly for patients who have high-risk cardiovascular diseases. This trend is being complemented by lifestyle-related conditions like obesity, diabetes, hypertension, and a sedentary lifestyle, which are aggregately causing increased rates of cardiovascular events. With the rising burden of heart disease, healthcare professionals are increasingly depending upon vascular closure devices to provide safe and successful post-procedure recovery.

Increased Use of Minimally Invasive Procedures

The need for vascular closure devices is being aggressively driven by the increasing use of minimally invasive cardiovascular procedures. Healthcare providers and patients are increasingly opting for catheter-based interventions such as stenting and angioplasty over open surgery due to shorter hospital stays, faster recovery periods, and lower risks of complications. Along with this trend, the demand for effective vascular closure devices is constantly on the rise, as they have a significant role in closing sites of arterial punctures after catheter-based procedures. Hospitals are implementing these devices to enhance procedural effectiveness and patient comfort, eliminating the use of cumbersome, time-consuming manual compression techniques. This has been prompted by continuous advances in interventional cardiology, where new procedures are being created that need efficient vascular access management. As minimally invasive interventions become more popular in both developed and developing healthcare markets, advanced closure devices are in high demand. IMARC Group predicts that the global minimally invasive surgery market is projected to attain USD 94.9 Billion by 2033.

Emerging Vascular Closure Technologies

The market for vascular closure devices is being driven by ongoing innovation in the technologies of the devices, which are making them safer, more effective, and easier to use. Companies are launching next-generation products that are being developed with better bioabsorbable material, minipuncture, and better seal mechanisms. These advancements are minimizing the risk of complications like bleeding, infection, and vascular injury and maximizing patient outcomes for recovery. Development and research initiatives are aimed at creating devices that are compatible with more patient anatomies and interventional procedures, which is broadening their usage in clinical practice. Hospitals and doctors are increasingly turning to these sophisticated solutions due to the fact that they are streamlining procedural workflows and lowering overall treatment expenses. With technological advancements continuing, the vascular closure device segment is increasing competition, compelling companies to continue innovating. In 2024, Haemonetics Corporation , a worldwide medical technology firm dedicated to providing cutting-edge solutions for improved patient results, revealed the complete market launch of its VASCADE MVP(R) XL mid-bore venous closure system. The VASCADE MVP XL system was launched for U.S. hospitals, representing the latest enhancement to Haemonetics' VASCADE(R) vascular closure systems, which incorporate advanced collapsible disc technology and a unique resorbable collagen patch aimed at facilitating swift hemostasis.

VASCULAR CLOSURE DEVICES MARKET GROWTH DRIVERS:

Greater Emphasis on Patient Comfort and Post-Procedural Recovery

The vascular closure devices sector is driven by the growing emphasis on enhancing patient comfort and speeding up post-procedural recovery. Manual compression, once the standard to close femoral artery punctures, is being linked with discomfort, increased bed rest duration, and heightened likelihood of patient dissatisfaction. Vascular closure devices, on the other hand, are delivering faster hemostasis, enabling patients to ambulate sooner and depart from the hospital sooner. This trend is in line with sweeping changes in healthcare that are focusing on patient-centered care and improved recovery pathways. Hospitals are evermore embracing closure devices as one of the measures in reducing patient length of stay and maximizing overall health care efficiency. The patients' demands for minimally invasive techniques that reduce pain and discomfort are also pushing the demand further. As patient satisfaction keeps becoming a vital indicator of health care quality, vascular closure devices are being evermore given priority in clinical practice globally.

Growth of Healthcare Infrastructure in Emerging Markets

The market for vascular closure devices is being boosted by the widespread growth of healthcare infrastructure in emerging economies. Nations in the Asia-Pacific, Latin American, and Middle Eastern regions are investing heavily in updating hospitals and gaining increased access to advanced interventional cardiology procedures. With increased healthcare spending and enhanced medical infrastructure, an increasing number of patients in these countries are seeking angioplasty and catheterization, which are necessitating efficient closure solutions. Governments and private healthcare organizations are placing greater emphasis on implementing advanced medical technologies to cater to increased cardiovascular treatment demands. This growth is providing manufacturers of vascular closure devices with the potential to enter new markets and build robust distribution channels. As education regarding cardiovascular well-being is on the increase and timely diagnosis is being encouraged, the use of closure devices is increasingly on the rise in these markets. This is assisting in the fact that the market is increasingly being supported by both established and developing healthcare systems.

Growing Clinical Evidence for Safety and Efficacy

The vascular closure device market is being supported by the increasing amount of clinical evidence that is proving their safety, reliability, and effectiveness when compared to standard manual compression techniques. Various studies and clinical trials are proving that vascular closure devices are decreasing time to hemostasis, decreasing complication rates, and allowing for quicker mobilization of the patient. This data is promoting doctors and hospitals to add closure devices as the standard of care in interventional cardiology procedures. Regulatory approvals are more and more being granted on the basis of these robust data sets, enabling manufacturers to increase product availability in multiple geographies. In addition, peer-reviewed studies are supporting confidence among the healthcare community, with physicians giving first priority to devices with documented outcomes for their patients. The expanding scientific evidence base is guaranteeing long-term confidence in these technologies, promoting uptake in various healthcare environments. As clinical evidence keeps mounting, vascular closure devices are becoming indispensable parts of contemporary cardiovascular therapy.

VASCULAR CLOSURE DEVICES INDUSTRY SEGMENTATION:

Breakup by Product:

  • Passive Approximators
    • Collagen Plugs
    • Sealant or Gel-Based Devices
    • Compression-Assist Devices
  • Active Approximators
    • Suture-Based Devices
    • Clip-Based Devices
  • External Hemostatic Devices

Passive approximators accounts for the majority of the market share

The passive approximators segment is driven by the increasing demand for MI surgical techniques in the healthcare industry. These devices are designed to achieve hemostasis at vascular access sites without active compression, thereby reducing patient discomfort and recovery time. The advancements in material science and device engineering play a crucial role in enhancing the efficacy and safety of passive approximators, ensuring reliable closure of puncture sites. Additionally, the segment benefits from growing regulatory approvals and clinical validations supporting their use in various interventional procedures, which bolsters market acceptance and adoption. Moreover, healthcare providers' preference for devices that offer predictable outcomes and minimize procedural complications contributes to the segment's growth. Apart from this, the shift towards outpatient care settings, driven by cost-efficiency and patient convenience, further propels the demand for passive approximators. The segment also benefits from strategic collaborations and partnerships among industry players to expand product offerings and geographic reach, fostering market expansion.

Breakup by Access:

  • Femoral Access
  • Radial Access

Femoral access accounts for the majority of the market share

The femoral access segment is driven by the increasing complexity and volume of cardiovascular interventions requiring reliable arterial access. As medical procedures become more intricate, especially in fields like interventional cardiology and radiology, the femoral artery remains a preferred route due to its size and accessibility for delivering devices such as stents and catheters. Healthcare providers favor femoral access for its direct access to major vessels, facilitating comprehensive treatment strategies and minimizing procedural risks associated with alternative access sites. Moreover, advancements in imaging technologies like fluoroscopy and ultrasound enhance the precision of femoral artery access, ensuring safer and more effective procedures. Apart from this, the femoral access segment benefits from continuous innovation in closure devices designed specifically for this route. These devices aim to streamline post-procedural hemostasis, reducing complications such as bleeding and infection, which are critical factors in patient recovery and outcome success. Innovations include bioresorbable plugs, suture-based closure systems, and collagen-based sealants, which provide tailored solutions for varying patient anatomies and procedural requirements.

Breakup by Procedure:

  • Interventional Cardiology
  • Interventional Radiology/Vascular Surgery

Interventional cardiology accounts for the majority of the market share

The interventional cardiology segment is driven by the increasing prevalence of CVDs globally. Conditions such as coronary artery disease and myocardial infarction continue to rise due to aging populations, sedentary lifestyles, and unhealthy dietary habits. This growing disease burden necessitates advanced treatment options like percutaneous coronary interventions (PCI) and transcatheter aortic valve replacements (TAVR), driving demand for interventional cardiology procedures. Moreover, technological advancements in imaging modalities, stents, and catheters enhance procedural efficacy and safety, attracting both patients and healthcare providers towards these MI interventions. The segment also benefits from the expanding role of preventive cardiology, promoting early detection and intervention to mitigate disease progression and reduce the need for more invasive treatments.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Hospitals accounts for the majority of the market share

The hospitals segment is driven by the increasing demand for specialized medical services and advanced treatments that require robust infrastructure and skilled healthcare professionals. Hospitals serve as primary centers for complex procedures and critical care, necessitating a wide range of medical devices, including imaging systems, surgical instruments, and patient monitoring equipment. This demand is further bolstered by the rising incidence of chronic diseases and age-related ailments, driving hospital admissions and the need for comprehensive medical interventions. Apart from this, technological advancements play a pivotal role in enhancing hospital capabilities, from telemedicine solutions that improve accessibility to advanced diagnostic tools that enable more accurate diagnoses and personalized treatment plans. The integration of electronic health records (EHRs) and digital health platforms also supports streamlined patient management and data-driven decision-making within hospital settings, contributing to operational efficiency and patient satisfaction.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest vascular closure devices market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America regional market is driven by the increasing prevalence of CVDs and the subsequent rise in vascular procedures. As one of the leading regions for healthcare innovation and adoption of advanced medical technologies, North America sees a high incidence of conditions like coronary artery disease and peripheral vascular disease, necessitating frequent interventions such as cardiac catheterizations and angioplasties. Vascular closure devices play a crucial role in these procedures, offering efficient hemostasis and reducing post-operative complications, which drives their widespread adoption in clinical practice. The North America regional market is further bolstered by robust technological advancements in vascular closure devices. Innovations such as bioresorbable implants, enhanced hemostatic agents, and improved deployment mechanisms are continually introduced, aiming to improve procedural outcomes and patient comfort. These technological advancements cater to the region's demand for state-of-the-art medical solutions, fostering a competitive market landscape where healthcare providers prioritize the latest advancements to enhance patient care.

Apart from this, the North America regional market is influenced by the stringent regulatory environment and favorable reimbursement policies. Regulatory bodies like the FDA (Food and Drug Administration) ensure the safety and efficacy of vascular closure devices through rigorous approval processes, instilling confidence among healthcare providers and patients. Concurrently, favorable reimbursement frameworks incentivize hospitals and healthcare facilities to adopt these devices, facilitating broader market penetration and sustained growth in the region.

COMPETITIVE LANDSCAPE:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the vascular closure devices include Abbott Laboratories, Cardiva Medical Inc. (Haemonetics Corporation), Cordis Corporation (Cardinal Health Inc.), ENDOCOR GmbH & Co. KG, Merit Medical Systems Inc., Morris Innovative Inc., Teleflex Incorporated, Terumo Medical Corporation (Terumo Corporation), Transluminal Technologies LLC, Vasorum Ltd., etc. ()
  • Key players in the vascular closure devices market are actively engaged in strategic initiatives aimed at expanding their product portfolios and geographical presence. These initiatives often include mergers, acquisitions, and partnerships with other companies to leverage complementary strengths and accelerate innovation. Companies are focusing on developing next-generation closure devices that offer enhanced safety, efficacy, and patient comfort, thereby differentiating their offerings in a competitive market landscape. Additionally, significant investments in research and development (R&D) are directed towards advancing technology, such as the use of bioresorbable materials and improved delivery mechanisms, to address evolving clinical needs and regulatory requirements. Market leaders are also intensifying efforts to strengthen their distribution networks and market penetration strategies, particularly in emerging economies where there is a growing demand for MI procedures. Furthermore, there is a concerted effort among these players to streamline manufacturing processes and reduce production costs to maintain competitive pricing and improve profitability.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vascular Closure Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Passive Approximators
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Collagen Plugs
      • 6.1.2.2 Sealant or Gel-Based Devices
      • 6.1.2.3 Compression-Assist Devices
    • 6.1.3 Market Forecast
  • 6.2 Active Approximators
    • 6.2.1 Market Trends
    • 6.2.1 Key Segments
      • 6.2.1.1 Suture-Based Devices
      • 6.2.1.2 Clip-Based Devices
    • 6.2.3 Market Forecast
  • 6.3 External Hemostatic Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Access

  • 7.1 Femoral Access
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Radial Access
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Procedure

  • 8.1 Interventional Cardiology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Interventional Radiology/Vascular Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cardiva Medical Inc. (Haemonetics Corporation)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Cordis Corporation (Cardinal Health Inc.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 ENDOCOR GmbH & Co. KG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Merit Medical Systems Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Morris Innovative Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Teleflex Incorporated
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Terumo Medical Corporation (Terumo Corporation)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Transluminal Technologies LLC
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Vasorum Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Vascular Closure Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Vascular Closure Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Vascular Closure Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Vascular Closure Devices Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Vascular Closure Devices Market: Breakup by Access (in %), 2025
  • Figure 6: Global: Vascular Closure Devices Market: Breakup by Procedure (in %), 2025
  • Figure 7: Global: Vascular Closure Devices Market: Breakup by End-User (in %), 2025
  • Figure 8: Global: Vascular Closure Devices Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Vascular Closure Devices (Passive Approximators) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Vascular Closure Devices (Passive Approximators) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Vascular Closure Devices (Active Approximators) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Vascular Closure Devices (Active Approximators) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Vascular Closure Devices (External Hemostatic Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Vascular Closure Devices (External Hemostatic Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Vascular Closure Devices (Femoral Access) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Vascular Closure Devices (Femoral Access) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Vascular Closure Devices (Radial Access) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Vascular Closure Devices (Radial Access) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Vascular Closure Devices (Interventional Cardiology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Vascular Closure Devices (Interventional Cardiology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Vascular Closure Devices (Interventional Radiology/Vascular Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Vascular Closure Devices (Interventional Radiology/Vascular Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Vascular Closure Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Vascular Closure Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Vascular Closure Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Vascular Closure Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Vascular Closure Devices (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Vascular Closure Devices (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: North America: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: North America: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: United States: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: United States: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Canada: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Canada: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Asia-Pacific: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Asia-Pacific: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: China: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: China: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Japan: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Japan: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: India: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: India: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: South Korea: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: South Korea: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Australia: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Australia: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Indonesia: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Indonesia: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Others: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Others: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Europe: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Europe: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Germany: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Germany: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: France: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: France: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: United Kingdom: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: United Kingdom: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Italy: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Italy: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Spain: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Spain: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Russia: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Russia: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Latin America: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Latin America: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Brazil: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Brazil: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Mexico: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Mexico: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Middle East and Africa: Vascular Closure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Middle East and Africa: Vascular Closure Devices Market: Breakup by Country (in %), 2025
  • Figure 77: Middle East and Africa: Vascular Closure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Global: Vascular Closure Devices Industry: Drivers, Restraints, and Opportunities
  • Figure 79: Global: Vascular Closure Devices Industry: Value Chain Analysis
  • Figure 80: Global: Vascular Closure Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vascular Closure Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Vascular Closure Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Vascular Closure Devices Market Forecast: Breakup by Access (in Million USD), 2026-2034
  • Table 4: Global: Vascular Closure Devices Market Forecast: Breakup by Procedure (in Million USD), 2026-2034
  • Table 5: Global: Vascular Closure Devices Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Vascular Closure Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Vascular Closure Devices Market: Competitive Structure
  • Table 8: Global: Vascular Closure Devices Market: Key Players